Evidence map›Paper›PMID 39929860›Full record

ArticleScientific reports2025

Identifying invasiveness to aid lung adenocarcinoma diagnosis using deep learning and pathomics.

Hai Du, Xiulin Wang, Kaifeng Wang, Qi Ai, Jing Shen, Ruiping Zhu, Jianlin Wu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hai Du *Department of Radiology, Ordos Central Hospital, Ordos Inner Mongolia, China.
Xiulin Wang *Stem Cell Clinical Research Center, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Kaifeng WangFujian Medical University, Fuzhou, Fujian, China.
Qi AiDepartment of Radiology, Affiliated Xinhua Hospital of Dalian University, Dalian, Liaoning, China.
Jing ShenDepartment of Radiology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China.
Ruiping ZhuDepartment of Pathology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China.
Jianlin WuDepartment of Radiology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China. cjr.wujianlin@vip.163.com.

Funding

Dalian Outstanding Young Technology Talents Program 2023RY034National Natural Science Foundation of China 82071911Natural Science Foundation of Inner Mongolia Autonomous Region 2023MS08031
6 · The paper itself

Abstract

Most classification efforts for primary subtypes of lung adenocarcinoma (LUAD) have not yet been integrated into clinical practice. This study explores the feasibility of combining deep learning and pathomics to identify tumor invasiveness in LUAD patients, highlighting its potential clinical value in assisting junior and intermediate pathologists. We retrospectively analyzed whole slide image (WSI) data from 289 patients with surgically resected ground-glass nodules (GGNs). First, three ResNet deep learning models were used to identify tumor regions. Second, features from the best-performing model were extracted to build pathomics using machine learning classifiers. Third, the accuracy of pathomics in predicting tumor invasiveness was compared with junior and intermediate pathologists' diagnoses. Performance was evaluated using the area under receiver operator characteristic curve (AUC). On the test cohort, ResNet18 achieved the highest AUC (0.956) and sensitivity (0.832) in identifying tumor areas, with an accuracy of 0.904; Random Forest provided high accuracy and AUC values of 0.814 and 0.807 in assessing tumor invasiveness. Pathology assistance improved diagnostic accuracy for junior and intermediate pathologists, with AUC values increasing from 0.547 to 0.759 and 0.656 to 0.769. This study suggests that deep learning and pathomics can enhance diagnostic accuracy, offering valuable support to pathologists.

Indexed as

Adenocarcinoma of LungDeep LearningLung NeoplasmsAgedArea Under CurveFemaleHumansMaleMiddle AgedNeoplasm InvasivenessRetrospective StudiesROC CurveDeep learningInvasivenessLung adenocarcinomaMachine learningPathomics

Identifiers

PMID39929860
PMCPMC11810995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.